Consistent with these studies, our findings showed that MSCs enhanced the effect of radiotherapy on tumors by inhibiting tumor cell proliferation and enhancing TRAIL-dependent cell death by promoting cGAS/STING-mediated type I production. This evidence concerns the gene TNFSF10 and neoplasm.